Theralase Technologies Inc. TLT.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -25.25% | 52.28% | -44.75% | -20.11% | 115.47% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.25% | 52.28% | -44.75% | -20.11% | 115.47% |
| Cost of Revenue | -22.16% | -8.29% | -93.44% | -17.96% | 37.15% |
| Gross Profit | -27.97% | 404.30% | -17.45% | -21.67% | 320.59% |
| SG&A Expenses | 19.79% | -11.01% | 7.37% | 3.63% | 6.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.70% | -22.93% | -30.97% | -0.69% | -4.75% |
| Operating Income | -8.99% | 27.53% | 24.88% | -6.39% | 15.39% |
| Income Before Tax | -11.52% | 26.63% | 25.02% | -6.88% | 16.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.52% | 26.63% | 25.02% | -6.88% | 16.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.52% | 26.63% | 25.02% | -6.88% | 16.95% |
| EBIT | -8.99% | 27.53% | 24.88% | -6.39% | 15.39% |
| EBITDA | -10.48% | 28.04% | 26.64% | -6.96% | 15.45% |
| EPS Basic | 3.57% | 31.71% | 26.92% | 0.00% | 22.22% |
| Normalized Basic EPS | 0.00% | 30.77% | 25.00% | 0.00% | 22.73% |
| EPS Diluted | 3.57% | 31.71% | 26.92% | 0.00% | 22.22% |
| Normalized Diluted EPS | 0.00% | 30.77% | 25.00% | 0.00% | 22.73% |
| Average Basic Shares Outstanding | 14.27% | 7.03% | 1.66% | 6.82% | 7.18% |
| Average Diluted Shares Outstanding | 14.27% | 7.03% | 1.66% | 6.82% | 7.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |